ADVENT On Air

About ADVENT On Air

The latest updates in type 2 inflammatory science, brought to you by leading experts in the field. The ADVENT On Air podcast will feature scientific conversations that explore new research into the pathologies and modalities for a range of diseases linked to type 2 inflammation (atopic dermatitis, asthma, prurigo nodularis, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis). This podcast is instrumental for healthcare professionals focused on allergy, dermatology, gastroenterology, and diseases of the upper and lower airways who want to stay at the forefront of this complex, evolving disease area. Subscribe to the ADVENT On Air podcast channel to receive notifications when new episodes are released. To explore additional educational materials for HCPs about dermatology, pulmonology, rhinology, and gastroenterology, visit ADVENTprogram.com. This podcast is produced as part of ADVENT, a medical education non-promotional program organized by Sanofi and Regeneron, and is intended for healthcare professionals. ©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2302644 v2.0 07/2023 MAT-US-2304947 v1.0-P Exp. Date 07/07/2025

Publisher

ADVENT Program

Category

health & fitness

Language

en

Explicit

No

First episode

31 Jul 2023

Latest episode

17 Aug 2026

Latest episodes

27 episodes in the feed.

1. 

   17 Aug 2026

   ADVENT AD Podcast: Atopic Dermatitis: Understanding Bone Health & Growth in Pediatric Atopic Dermatitis

   In this episode, Dr. Amy Paller and Dr. Lisa Swanson as they delve into the risk of low bone mineral density and impaired growth reported in pediatric atopic dermatitis and observed improvements in growth observed with advanced therapy, especially among children with shorter stature at baseline. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. · Disclaimer: o This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. o The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. o The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. · Speaker disclosures: o Lisa Swanson, MD, FAAD, has served as an investigator for Arcutis, Castle, Organon, and Sun. Dr. Swanson has participated as a speaker for AbbVie, Arcutis, Galderma, Incyte, Johnson & Johnson, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. In addition, she has served as a consultant and advisory board member for AbbVie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Chiesi, Galderma, Incyte, Johnson & Johnson, Leo, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. o Amy Paller, MD, MS, has served as an advisor and consultant and has received grant funding from AbbVie, Abeona, Aegerion Pharmaceuticals, Azitra, BioCryst, Boehringer Ingelheim, Bristol Myers Squibb, Castle Creek Biosciences, Catawba, Eli Lilly and Company, Galderma, Gilead, InMed Pharmaceuticals, Janssen, Krystal Biotech, LEO Pharma, Novartis, Regeneron, Sanofi/Genzyme, Seanergy (consultant with honorarium), TWi Biotechnology, and UCB. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2600170 – 1.0 – 07/2026 Course Descriptors: MAT-GLB-2604085 – 1.0 – 07/2026

2. 

   7 May 2026

   The Multifaceted Patient Burden and Drivers of Disease in Prurigo Nodularis

   In this episode, Dr. Sarina Elmariah and Dr. Brian Kim explore prurigo nodularis (PN), with a focus on severe itch, fibrotic skin lesions, and their impact on patients’ quality of life. They discuss PN epidemiology, common comorbidities, and the challenges of managing multimorbid patients, while breaking down the neuroimmune mechanisms, highlighting the role of type 2 cytokines in itch and lesion development. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. Speaker disclosures: Sarina Elmariah, MD, PhD, MPH has the following interests to disclose: Consultant, advisor, or investigator: Bambusa Therapeutics, Celldex, Disc Medicine, Galderma, Incyte, Novartis, Pfizer, Regeneron, Sanofi, ZenZema Brian Kim, MD, is co-founder of Alys Pharmaceuticals and Neurommune Therapeutics; he has served as a consultant for ABRAX Japan, AbbVie, Amgen, Attovia Therapeutics, Eli Lilly and Company, Evommune, Galderma, Gilead, LEO Pharma, Neurocrine, Novartis, Pfizer, Recens Medical, Regeneron, Sanofi, Septerna, Triveni Bio; he has stock in ABRAX Japan, Alys Pharamaceuticals, Attovia Therapeutics, Locus Biosciences, Neurommune Therapeutics, Recens Medical, and Triveni Bio. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2504334 – 1.0 – 05/2026 MAT-US-2604824 v1.0 - P Expiration Date: 05/4/2028

3. 

   16 Apr 2026

   Breaking the Cycle: The OCS Burden in CRSwNP

   Listen to experts, Dr. Amber Luong and Dr. Marjolein Cornet, discuss the significant burden of oral corticosteroid (OCS) use in chronic rhinosinusitis with nasal polyps (CRSwNP) and its short-term, long-term, and cumulative risks, particularly for patients with coexisting conditions like asthma. Experts highlight the need for improved multidisciplinary approaches and OCS-sparing strategies to optimize patient care. ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. This podcast is intended for healthcare professionals only. Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: Luong: Served on advisory boards for AstraZeneca, GlaxoSmithKline, Sanofi and Regeneron; Consultant to Maxwell Biosciences, Medtronic and Stryker; Grant funding from Eli Lily and Sanofi. Cornet: Marjolein Cornet has received speaker fees and participated in advisory board meetings for Regeneron Pharmaceuticals Inc., Sanofi Genzyme, GSK, ALK, Mylan, Stallergenes Greer and Medtronic. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2601160- 1.0 - 04/2026

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

4.7 / 5

14 ratings

Spotify

5.0 / 5

9 ratings

Podcast Authority Score: 33 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

18

Social presence

97

YouTube

0

Engagement

71

Contact ADVENT On Air

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.